Abstract:Main Points Silencing pyruvate dehydrogenase kinase 2 in SOD1G93A astrocytes reduces pyruvate dehydrogenase phosphorylation. Silenced astrocytes recover mitochondrial bioenergetics and morphology. This metabolic reprogramming restores the ability of astrocytes to support motor neuron survival. Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron (MN) degeneration. Various studies using cellular and animal models of ALS indicate that there is a complex interplay between MN and neighboring non‐neuronal cells, such as astrocytes, resulting in noncell autonomous neurodegeneration. Astrocytes in ALS exhibit a lower ability to support MN survival than nondisease‐associated ones, which is strongly correlated with low‐mitochondrial respiratory activity. Indeed, pharmacological inhibition of pyruvate dehydrogenase kinase (PDK) led to an increase in the mitochondrial oxidative phosphorylation pathway as the primary source of cell energy in SOD1G93A astrocytes and restored the survival of MN. Among the four PDK isoforms, PDK2 is ubiquitously expressed in astrocytes and presents low expression levels in neurons. Herein, we hypothesize whether selective knockdown of PDK2 in astrocytes may increase mitochondrial activity and, in turn, reduce SOD1G93A‐associated toxicity. To assess this, cultured neonatal SOD1G93A rat astrocytes were incubated with specific PDK2 siRNA. This treatment resulted in a reduction of the enzyme expression with a concomitant decrease in the phosphorylation rate of the pyruvate dehydrogenase complex. In addition, PDK2‐silenced SOD1G93A astrocytes exhibited restored mitochondrial bioenergetics parameters, adopting a more complex mitochondrial network. This treatment also decreased lipid droplet content in SOD1G93A astrocytes, suggesting a switch in energetic metabolism. Significantly, PDK2 knockdown increased the ability of SOD1G93A astrocytes to support MN survival, further supporting the major role of astrocyte mitochondrial respiratory activity in astrocyte‐MN interactions. These results suggest that PDK2 silencing could be a cell‐specific therapeutic tool to slow the progression of ALS.

Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model

TNFα prevents FGF4-mediated rescue of astrocyte dysfunction and reactivity in human ALS models

Neurotoxic reactive astrocytes are induced by activated microglia

The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity

Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model

Glial state changes and neuroinflammatory RIPK1 signaling are a key feature of ALS pathogenesis

Depletion of Reduced Glutathione Enhances Motor Neuron Degeneration in Vitro and in Vivo

The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis

Knockout of Dectin-1 does not modify disease onset or progression in a MATR3 S85C knock-in mouse model of ALS

A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis

Inhibition of PHLDA3 expression in human superoxide dismutase 1-mutant amyotrophic lateral sclerosis astrocytes protects against neurotoxicity

Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression

Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation

Pyruvate dehydrogenase kinase 2 knockdown restores the ability of amyotrophic lateral sclerosis‐linked SOD1G93A rat astrocytes to support motor neuron survival by increasing mitochondrial respiration

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease

Early nuclear phenotypes and reactive transformation in human iPSC-derived astrocytes from ALS patients with SOD1 mutations

Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model

Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity

IRAK-M Plays A Role in the Pathology of Amyotrophic Lateral Sclerosis Through Suppressing the Activation of Microglia

Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia

A molecular switch for neuroprotective astrocyte reactivity